Two very different kinds of project
Care providers, such as polyclinics, dental and dermatology centres, day-surgery units, diagnostic centres and home healthcare, are service businesses. Their numbers depend on catchment, specialty mix, clinician productivity and the payer mix between insurers and self-pay patients. Finance usually comes from banks, often under the Kafalah guarantee for smaller operators, or from investors.
Manufacturers of medicines, medical devices and consumables are industrial projects. They need product registration with the Saudi Food and Drug Authority and good manufacturing practice certification, and they are financed much like other factories, typically through SIDF.
What decides a clinic's numbers
- Catchment population, competition within driving distance and the gaps in specialties
- Patients per clinician per day, and how quickly each specialty fills its diary
- Payer mix and insurer tariffs, and how long claims take to be paid
- Licensing timelines with the Ministry of Health and the cost of the fit-out to meet them
- Recruiting and retaining clinicians, including Saudisation in healthcare roles
What decides a manufacturing plant's numbers
- Registration timelines, which push first revenue back, sometimes by years
- Procurement channels, including the large share of demand that flows through government and unified purchasing
- Cleanroom, quality control and validation costs, which are high and front-loaded
- Technology transfer or licensing agreements with an originator company
What the study covers
- Demand by specialty or product, from population, utilisation and import data
- Regulatory path, licences and realistic timelines to first revenue
- Facility programme, equipment list and fit-out or plant cost
- Staffing plan by role, with clinician and pharmacist availability
- Revenue build by specialty, payer or channel, and a ramp-up that reflects the regulator, not the brochure
Questions we're asked
Can you assess a new clinic location?
Yes. We compare catchment, competition and specialty gaps for the sites you're considering, then model the one that stacks up best in full.
Do you handle Ministry of Health or SFDA applications?
No. We build the regulatory steps and timelines into the study and model. The applications themselves are made by you or a regulatory specialist, and we work alongside them.
Can the study support a partnership with an international healthcare brand?
Yes. Studies for joint ventures and licensing deals set out what each side contributes and how the returns are shared, as well as the market case.